Skip to main content
Clinical Trials/NCT01869452
NCT01869452
Completed
Not Applicable

Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease

Resicard4 sites in 1 country555 target enrollmentMay 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Resicard
Enrollment
555
Locations
4
Primary Endpoint
number of patient with a better of quality of life
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Detailed Description

Patients are assigned to an arm accordingly to their needs: class 1 with light therapeutic education, class 2 with moderate education, class 3 with heavy education. Assignement is based on the first education diagnosis during hospitalization time. Quality of life and patient's knowledge are regularly evaluated through questionnaires

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
June 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Resicard
Responsible Party
Principal Investigator
Principal Investigator

Pr Ariel Cohen

head of the departement of cardiology,Saint Antoine hospital , Paris

Resicard

Eligibility Criteria

Inclusion Criteria

  • hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina)
  • hospitalization for heart failure
  • acute coronary syndrome \< 3 months
  • heart failure \< 3 months
  • coronary by-pass surgery \< 3 months

Exclusion Criteria

  • complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock)
  • valvular cardiac pathology
  • obstructive cardiomyopathy
  • planned cardiac transplantation
  • severe neurological or psychiatric troubles
  • loss of autonomy
  • other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)

Outcomes

Primary Outcomes

number of patient with a better of quality of life

Time Frame: 1 year

quality of life is evaluated with appropriate questionnaires

Secondary Outcomes

  • number of hospitalizations during the follow up(1 year)
  • number of patients who improve their knowledge of disease(1 year)

Study Sites (4)

Loading locations...

Similar Trials